INS and obesity disorder: Notably, while both HFD and HFD + STZ groups exhibit obesity-related metabolic perturbations, the HFD + STZ group displays broader and more severe disruptions, consistent with an insulin-resistant phenotype involving systemic inflammation, impaired glucose handling, and altered gut–liver axis communication.